Misoprostol before planned c-section
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests if giving misoprostol before a planned c-section can help reduce bleeding. It might make the surgery safer for women who meet certain criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned (elective) c-section
- You are younger than 35 years old
- You are less than 38 weeks pregnant (confirmed by ultrasound or last period date)
- You are carrying one baby with no major birth defects
- You have not had 2 or more previous c-sections
- You do not have conditions like preeclampsia, diabetes, low amniotic fluid, or growth problems with the baby
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of using misoprostol (a medicine that helps the uterus contract) to prevent heavy bleeding after a C-section. One group gets a vaginal tablet before the surgery, the other gets a tablet under the tongue after the surgery.
This trial tests if giving a medication called misoprostol as a rectal suppository can help reduce bleeding during a planned cesarean section. If you are having a planned cesarean and are generally healthy, this study might be an option for you.
This trial tests a medication called misoprostol to help the body expel pregnancy tissue after a fetal death between 18 and 24 weeks. It may be an option for women who have not had a previous C-section or have had only one.
This trial tests if giving misoprostol before surgery can reduce blood loss during the removal of uterine fibroids (non-cancerous growths). It is for women who need laparoscopic or open surgery for their fibroids.
This trial tests whether taking letrozole before misoprostol shortens the time needed to complete a missed abortion, which is when the pregnancy stops developing but the body hasn't expelled the tissue. If effective, it could reduce the waiting time and make the process more efficient.
This trial tests if misoprostol, a medication that softens the cervix, helps make hysteroscopic myomectomy (a procedure to remove fibroids through the vagina) easier or safer. It is for women with small, inner-womb fibroids who are scheduled for this surgery.
Hear when a new Caesarean Section trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.